Table 4.
Outcome of Interest | Data Point | Complete Dataset | Cervicothoracic | Shoulder Girdle | Lumbopelvic | Lower Extremity |
---|---|---|---|---|---|---|
PSFS | Intake | 4.9 ± 1.8 | 5.7 ± 1.4 | 4.1 ± 1.7 | 5.1 ± 2.1 | 5.0 ± 1.6 |
Final Assessment | 8.1 ± 1.7 | 9.3 ± 0.9 | 7.8 ± 1.4 | 8.1 ± 1.5 | 7.9 ± 2.0 | |
Change | 3.1 (2.6, 3.7) * | 3.6 (1.9, 5.34) | 3.7 (2.6, 4.8) * | 3.0 (2.0, 4.1) * | 2.9 (2.1, 3.7) * | |
Region-Specific Questionnaire | Intake | - | 20.4 ± 7.4 | 21.3 ± 8.9 | 22.9 ± 15.1 | 61.7 ± 8.7 |
Final Assessment | - | 7.6 ± 7.4 | 10.5 ± 14.9 | 9.0 ± 10.0 | 71.5 ± 10.8 | |
Change | - | 12.8 (2.0, 23.6) | 10.8 (2.0, 19.6) * | 13.9 (6.3, 21.5) * | 9.9 (5.6, 14.2) * | |
Number of Dysfunctional Patterns | Intake | 9.3 ± 2.3 | 11.0 ± 2.7 | 9.4 ± 1.9 | 9.4 ± 2.0 | 8.9 ± 2.6 |
Final Assessment | 8.9 ± 2.2 | 8.8 ± 1.6 | 9.6 ± 2.7 | 8.3 ± 1.8 | 8.9 ± 2.2 | |
Change | 0.4 (-0.3, 1.1) | 2.2 (-1.1, 5.5) | -0.2 (-1.9, 1.5) | 1.1 (-0.04, 2.2) * | 0.1 (-1.0, 1.1) | |
Number of Painful Patterns | Intake | 1.6 ± 2.1 | 3.2 ± 3.8 | 1.7 ± 1.5 | 2.8 ± 2.6 | 0.7 ± 1.0 |
Final Assessment | 0.5 ± 1.1 | 0.4 ± 0.9 | 0.6 ± 1.0 | 1.0 ± 1.7 | 0.3 ± 0.6 | |
Change | 1.1 (0.6, 1.6) * | 2.8 (−1.3, 6.9) | 1.1 (0.2, 2.0) * | 1.8 (0.5, 3.2) * | 0.5 (0.1, 0.8) * | |
SFMA Criterion Score | Intake | 14.2 ± 4.5 | 17.0 ± 5.0 | 14.1 ± 4.5 | 14.8 ± 4.2 | 13.5 ± 4.6 |
Final Assessment | 13.3 ± 3.9 | 13.2 ± 2.5 | 13.6 ± 4.7 | 12.9 ± 2.7 | 13.4 ± 4.4 | |
Change | 0.8 (−0.5, 2.1) | 3.8 (−2.0, 9.6) | 0.5 (−2.8, 3.8) | 1.8 (−0.3, 3.9) * | 0.02 (−2.0, 2.0) |
Results for intake and final assessment scores are reported as mean ± standard deviation. Results for change scores are reported as mean (95% confidence interval) with values normalized such that positive numbers indicate improvement on the scale used. Region-specific questionnaires used were Neck Disability Index (0-100%), Quick Disabilities of the Arm, Shoulder, and Hand (0-100%), Oswestry Disability Index (0-100%), and Lower Extremity Functional Scale (0-80).
indicates an associated p-value of < 0.05 obtained in Wilcoxon signed-rank test comparison of intake to discharge scores.